EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 39 filers reported holding EVOGENE LTD in Q1 2022. The put-call ratio across all filers is 4.83 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $96,000 | -5.0% | 117,000 | 0.0% | 0.07% | -2.7% |
| Q2 2022 | $101,000 | -33.6% | 117,000 | 0.0% | 0.07% | -11.0% |
| Q1 2022 | $152,000 | -17.8% | 117,000 | +3.5% | 0.08% | +22.4% |
| Q4 2021 | $185,000 | +160.6% | 113,000 | +648.3% | 0.07% | +116.1% |
| Q4 2020 | $71,000 | -67.6% | 15,100 | -71.8% | 0.03% | -74.4% |
| Q3 2020 | $219,000 | +236.9% | 53,600 | -17.0% | 0.12% | +168.9% |
| Q2 2020 | $65,000 | -36.3% | 64,600 | +1.6% | 0.04% | -16.7% |
| Q2 2019 | $102,000 | -37.4% | 63,600 | +96.9% | 0.05% | -42.6% |
| Q2 2017 | $163,000 | -5.2% | 32,300 | 0.0% | 0.09% | -21.0% |
| Q1 2017 | $172,000 | -29.2% | 32,300 | -32.3% | 0.12% | -14.4% |
| Q4 2016 | $243,000 | +97.6% | 47,700 | +147.2% | 0.14% | +82.9% |
| Q3 2016 | $123,000 | -8.9% | 19,300 | -10.6% | 0.08% | -8.4% |
| Q2 2016 | $135,000 | -99.9% | 21,600 | +2.4% | 0.08% | -11.7% |
| Q1 2016 | $138,205,000 | +99328.1% | 21,100 | +22.0% | 0.09% | +13.3% |
| Q4 2015 | $139,000 | – | 17,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eidelman Virant Capital | 117,000 | $101,000 | 0.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,322 | $156,000 | 0.05% |
| Senvest Management, LLC | 230,606 | $178,000 | 0.01% |
| Susquehanna International Group Ltd. | 28,718 | $21,000 | 0.01% |
| Vident Investment Advisory, LLC | 87,714 | $68,000 | 0.00% |
| MGO ONE SEVEN LLC | 15,340 | $12,000 | 0.00% |
| Csenge Advisory Group | 31,962 | $24,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $8,000 | 0.00% |
| Sigma Planning Corp | 31,810 | $24,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,249 | $8,000 | 0.00% |